Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Chin J Integr Med ; 24(2): 125-132, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27164963

RESUMEN

OBJECTIVE: To investigate the protective effects of Chinese medicine formulation Chaihu Shugan San (, CHSGS) on nonalcoholic fatty liver disease (NAFLD) in rats with insulin resistance (IR) and its molecular mechanisms. METHODS: Male Sprague-Dawley rats were randomly divided into six groups: the control group, the model group, Dongbao Gantai group (, DBGT, 0.09 g methionine/kg), CHSGS high-dose group (CHSG-H, 12.6 g crude drug/kg), CHSGS medium-dose group (CHSG-M, 6.3 g crude drug/kg), and CHSGS low-dose group (CHSG-L, 3.15 g crude drug/kg). After establishing the NAFLD rat model and treatment for 8 weeks, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), free fatty acid (FFA), fasting blood glucose (FBG), fasting insulin (FINS) contents in blood serum, and TC, TG contents in the hepatic homogenate were measured by an automatic biochemical analyzer, and a homeostasis model assessment was applied to assess the status of IR, insulin sensitivity index (ISI), and homeostasis model assessment for insulin secretion (HOMA-IS). The expression levels of adiponectin and leptin mRNA in liver tissue were analyzed by reverse transcription polymerase chain reaction. Pathological changes of livers were observed by hematoxylin-eosin staining of paraffin section. RESULTS: Compared with the model group, the serum levels of TC, TG, FFA, FBG, FINS, IRI, ISI, and the liver levels of TC and TG in CHSG-H, CHSG-M, CHSG-L groups showed significant declines (P<0.01 or P<0.05); the serum levels of HDL-C, HOMA-IS were significantly increased (P<0.01 or P<0.05); the expression of leptin mRNA was dramatically decreased and the expression of adiponectin mRNA was increased in the hepatic tissue (P<0.01 or P<0.05). The fatty deposition of liver cells could also be alleviated. CONCLUSION: CHSGS could up-regulate the expression of adiponectin mRNA and down-regulate the expression of leptin mRNA on the liver, suggesting the CHSGS had positive therapeutic effect on NAFLD in rats with IR.


Asunto(s)
Resistencia a la Insulina , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Enfermedad del Hígado Graso no Alcohólico/patología , Extractos Vegetales/uso terapéutico , Sustancias Protectoras/uso terapéutico , Adiponectina/genética , Adiponectina/metabolismo , Animales , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Ayuno/sangre , Homeostasis , Insulina/sangre , Leptina/genética , Leptina/metabolismo , Lípidos/análisis , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Enfermedad del Hígado Graso no Alcohólico/sangre , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Sprague-Dawley
2.
Zhong Yao Cai ; 35(11): 1809-13, 2012 Nov.
Artículo en Chino | MEDLINE | ID: mdl-23627095

RESUMEN

OBJECTIVE: To study the effect of HGD on diabetic cardiomyopathy and its mechanism. METHODS: The T2-DM rats model was established by combining high fat diet with STZ. The blood glucose, insulin, myocardial fibrosis and TGF-beta1/Smad3 signaling pathway were observed; TGF-beta1 and Smad3 mRNA expression were detected by RT-PCR method, protein expression detected by immunohistochemical method. RESULTS: HGD obviously reduced fasting blood glucose, insulin, improved insulin resistance, reduced myocardial hydroxyproline contents, lowered cardiac index, significantly inhibited over-expression of TGF-beta1/SMAD3 mRNA and protein in diabetic rats cardiac. CONCLUSION: HGD can obviously prevent experimental diabetic myocardial fibrosis through the regulation effect on TGFbeta1/Smad3 signaling pathway.


Asunto(s)
Diabetes Mellitus Experimental/complicaciones , Cardiomiopatías Diabéticas/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Proteína smad3/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Animales , Glucemia/metabolismo , Diabetes Mellitus Experimental/metabolismo , Cardiomiopatías Diabéticas/etiología , Cardiomiopatías Diabéticas/metabolismo , Combinación de Medicamentos , Medicamentos Herbarios Chinos/uso terapéutico , Masculino , Miocardio/metabolismo , Miocardio/patología , Plantas Medicinales/química , ARN Mensajero/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Proteína smad3/genética , Factor de Crecimiento Transformador beta1/genética
3.
Zhong Yao Cai ; 35(12): 1981-5, 2012 Dec.
Artículo en Chino | MEDLINE | ID: mdl-23705365

RESUMEN

OBJECTIVE: To examine the antifungal effect of different extract of Dryopteris fragrans (L.) Schott. in vitro, and screen the effective fraction from those extracts. METHODS: Separated the Dryopteris fragrans extract and got four parts by refluxing extraction,and determined the contents of total phloroglucinol. Disc agar diffusion method and solid agar dilution method were used to determine inhibitory effect. Minimum inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of different parts of Dryopteris fragrans extract against four strains of common clinical dermatophytes were investigated. RESULTS: The data showed that the contents sequence of total phloroglucinol was in the following order: 95% -ethanol extract > water extract > diethyl ether extract > petroleum ether extract, and the antimicrobial activities against the four dermatophytes were as following order: 95% -ethanol extract > water extract > di-ethyl ether extract > petroleum ether extract. CONCLUSION: The contents of total phloroglucinol in 95% -ethanol extract of Dryopteris fragrans is the highest, and the antifungal activity against dermatophytes in vitro is the strongest. The effective fraction of Dryopteris fragrans is the 95%-ethanol extract.


Asunto(s)
Antifúngicos/farmacología , Dryopteris/química , Hongos/efectos de los fármacos , Extractos Vegetales/farmacología , Antifúngicos/aislamiento & purificación , Arthrodermataceae/efectos de los fármacos , Epidermophyton/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Microsporum/efectos de los fármacos , Floroglucinol/análisis , Floroglucinol/farmacología , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Trichophyton/efectos de los fármacos
4.
Zhong Yao Cai ; 33(8): 1285-9, 2010 Aug.
Artículo en Chino | MEDLINE | ID: mdl-21213542

RESUMEN

OBJECTIVE: To observe the effect of fufang zhenzhu tiaozhi capsule (FTZ) on lipid metabolism in atherosclerotic rabbits. METHODS: 50 rabbits were divided into five groups: normal control group, model group, simvastatin group, the high-dose group and low-dose group of FTZ. The atherosclerotic model was established by feeding the rabbits with high fat diet. The medicine interfered groups were administrated with homologous medicine on the base of high fat diet. All the rabbits were fed for 12 weeks. The blood lipids levels were determined just before the experiment and at the forth, the eighth and the twelfth weekend of the experiment. At the end of the experiment, serum apolipoprotein levels, liver lipid contents and the area of atherosclerotic plaque were determined respectively. RESULTS: Compared with model group, TC, TG, LDL-C and ApoB levels were significantly decreased in FTZ groups (P < 0.05 or P < 0.01). The level of HDL-C and the ratio of ApoA I /ApoB were raised significantly (P < 0.05). The contents of TC,TG in liver tissue and the area percentage of atherosclerotic plaque were also markedly reduced (P < 0.05 or P < 0.01) in the FTZ groups. CONCLUSION: FTZ could efficiently regulate the abnormality of lipid metabolism in experimental atherosclerotic rabbits, and this maybe one mamechanisms of its antiatherogenic effect.


Asunto(s)
Aterosclerosis/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Triglicéridos/sangre , Animales , Apolipoproteínas/sangre , Aterosclerosis/sangre , Aterosclerosis/prevención & control , Cápsulas , Colesterol/sangre , Colesterol/metabolismo , Modelos Animales de Enfermedad , Combinación de Medicamentos , Medicamentos Herbarios Chinos/administración & dosificación , Femenino , Hiperlipidemias/sangre , Hiperlipidemias/prevención & control , Hipolipemiantes/administración & dosificación , Ligustrum/química , Hígado/metabolismo , Masculino , Plantas Medicinales/química , Placa Aterosclerótica/patología , Conejos , Distribución Aleatoria , Triglicéridos/metabolismo
5.
Zhong Yao Cai ; 32(8): 1285-7, 2009 Aug.
Artículo en Chino | MEDLINE | ID: mdl-19960955

RESUMEN

OBJECTIVE: To investigate the anti-hypoxia active fraction of Xiangdan injection. METHODS: The anti-hypoxia experiment under normal pressure with mice was adopted on the basis of orthogonal design, and a support vector machine model was established for pharmacodynamics prediction of TCM prescriptions. Moreover, the anti-hypoxia active fraction of Xiangdan injection was determined by experimental confirmation. RESULTS: The prediction model established in this study could predict the drug actions of different formulas. CONCLUSION: As indicated in model prediction and experimental confirmation, the pharmacodynamic actions of several formulas are superior to that of the original formula, and ADE has the best effect.


Asunto(s)
Algoritmos , Inteligencia Artificial , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Hipoxia/tratamiento farmacológico , Animales , Combinación de Medicamentos , Diseño de Fármacos , Interacciones Farmacológicas , Medicamentos Herbarios Chinos/administración & dosificación , Femenino , Hipoxia/mortalidad , Inyecciones Intraperitoneales , Masculino , Ratones , Distribución Aleatoria , Rutaceae/química , Salvia miltiorrhiza/química , Solventes/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA